AMPH logo

Amphastar Pharmaceuticals (AMPH) Net Income

Annual Net Income

$137.54 M
+$46.16 M+50.51%

31 December 2023

AMPH Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

$40.43 M
+$2.48 M+6.54%

30 September 2024

AMPH Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

$157.72 M
-$8.79 M-5.28%

30 September 2024

AMPH TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AMPH Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+50.5%-17.9%+16.6%
3 y3 years+9703.6%+36.8%+337.1%
5 y5 years+2497.1%+2986.2%+204.3%

AMPH Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+9703.6%-17.9%+154.7%-5.3%+337.1%
5 y5 yearsat high+2497.1%-17.9%+744.5%-5.3%>+9999.0%
alltimeall timeat high+1385.6%-17.9%+666.1%-5.3%+1136.8%

Amphastar Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sept 2024
-
$40.43 M(+6.5%)
$157.72 M(-5.3%)
June 2024
-
$37.95 M(-12.1%)
$166.51 M(+7.6%)
Mar 2024
-
$43.18 M(+19.4%)
$154.69 M(+12.5%)
Dec 2023
$137.54 M(+50.5%)
$36.17 M(-26.5%)
$137.54 M(+1.7%)
Sept 2023
-
$49.22 M(+88.4%)
$135.29 M(+32.7%)
June 2023
-
$26.12 M(+0.4%)
$101.94 M(+9.4%)
Mar 2023
-
$26.03 M(-23.2%)
$93.17 M(+1.9%)
Dec 2022
$91.39 M(+47.1%)
$33.91 M(+113.6%)
$91.39 M(+18.3%)
Sept 2022
-
$15.87 M(-8.5%)
$77.23 M(-15.0%)
June 2022
-
$17.35 M(-28.5%)
$90.91 M(+11.8%)
Mar 2022
-
$24.25 M(+22.7%)
$81.33 M(+30.9%)
Dec 2021
$62.12 M(+4327.4%)
$19.76 M(-33.1%)
$62.12 M(+72.1%)
Sept 2021
-
$29.55 M(+280.4%)
$36.08 M(+245.2%)
June 2021
-
$7.77 M(+54.1%)
$10.45 M(+319.0%)
Mar 2021
-
$5.04 M(-180.4%)
$2.50 M(+77.8%)
Dec 2020
$1.40 M(-97.1%)
-$6.27 M(-260.1%)
$1.40 M(-78.9%)
Sept 2020
-
$3.92 M(-2141.1%)
$6.65 M(+64.6%)
June 2020
-
-$192.00 K(-104.9%)
$4.04 M(-92.2%)
Mar 2020
-
$3.95 M(-484.9%)
$52.02 M(+6.3%)
Dec 2019
$48.94 M(-952.9%)
-$1.03 M(-178.3%)
$48.94 M(-5.6%)
Sept 2019
-
$1.31 M(-97.3%)
$51.83 M(-2.0%)
June 2019
-
$47.79 M(+5405.4%)
$52.91 M(+2229.9%)
Mar 2019
-
$868.00 K(-53.5%)
$2.27 M(-139.6%)
Dec 2018
-$5.74 M
$1.87 M(-21.9%)
-$5.74 M(-15.8%)
DateAnnualQuarterlyTTM
Sept 2018
-
$2.39 M(-183.7%)
-$6.82 M(-25.1%)
June 2018
-
-$2.85 M(-60.0%)
-$9.11 M(+112.7%)
Mar 2018
-
-$7.14 M(-1007.4%)
-$4.28 M(-214.2%)
Dec 2017
$3.65 M(-62.9%)
$787.00 K(+694.9%)
$3.75 M(-865.5%)
Sept 2017
-
$99.00 K(-95.0%)
-$490.00 K(-114.8%)
June 2017
-
$1.97 M(+120.8%)
$3.30 M(-59.9%)
Mar 2017
-
$893.00 K(-125.9%)
$8.22 M(-16.3%)
Dec 2016
$9.82 M(-452.4%)
-$3.45 M(-188.8%)
$9.82 M(-52.8%)
Sept 2016
-
$3.89 M(-43.6%)
$20.81 M(+49.6%)
June 2016
-
$6.89 M(+177.0%)
$13.91 M(+3689.9%)
Mar 2016
-
$2.49 M(-67.0%)
$367.00 K(-113.2%)
Dec 2015
-$2.79 M(-74.0%)
$7.53 M(-350.4%)
-$2.79 M(-78.3%)
Sept 2015
-
-$3.01 M(-54.7%)
-$12.84 M(-15.6%)
June 2015
-
-$6.65 M(+899.5%)
-$15.21 M(+56.1%)
Mar 2015
-
-$665.00 K(-73.6%)
-$9.74 M(-8.9%)
Dec 2014
-$10.70 M(-190.2%)
-$2.52 M(-53.1%)
-$10.70 M(+68.5%)
Sept 2014
-
-$5.38 M(+355.8%)
-$6.35 M(+462.4%)
June 2014
-
-$1.18 M(-27.1%)
-$1.13 M(-114.4%)
Mar 2014
-
-$1.62 M(-188.5%)
$7.86 M(-33.7%)
Dec 2013
$11.86 M(-34.4%)
$1.83 M(-1250.3%)
$11.86 M(+18.2%)
Sept 2013
-
-$159.00 K(-102.0%)
$10.03 M(-1.6%)
June 2013
-
$7.81 M(+227.9%)
$10.19 M(+327.9%)
Mar 2013
-
$2.38 M
$2.38 M
Dec 2012
$18.09 M(+133.4%)
-
-
Dec 2011
$7.75 M
-
-

FAQ

  • What is Amphastar Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals annual net income year-on-year change?
  • What is Amphastar Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals quarterly net income year-on-year change?
  • What is Amphastar Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals TTM net income year-on-year change?

What is Amphastar Pharmaceuticals annual net profit?

The current annual net income of AMPH is $137.54 M

What is the all time high annual net income for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high annual net profit is $137.54 M

What is Amphastar Pharmaceuticals annual net income year-on-year change?

Over the past year, AMPH annual net profit has changed by +$46.16 M (+50.51%)

What is Amphastar Pharmaceuticals quarterly net profit?

The current quarterly net income of AMPH is $40.43 M

What is the all time high quarterly net income for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high quarterly net profit is $49.22 M

What is Amphastar Pharmaceuticals quarterly net income year-on-year change?

Over the past year, AMPH quarterly net profit has changed by -$8.79 M (-17.86%)

What is Amphastar Pharmaceuticals TTM net profit?

The current TTM net income of AMPH is $157.72 M

What is the all time high TTM net income for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high TTM net profit is $166.51 M

What is Amphastar Pharmaceuticals TTM net income year-on-year change?

Over the past year, AMPH TTM net profit has changed by +$22.43 M (+16.58%)